Sunshine Biopharma Inc (NASDAQ:SBFM) currently has a daily average trading volume of 2.95M but it saw 1197653 shares traded in last market. With a market cap of 6.30M USD, the company’s current market price of $0.27 came falling about -6.01 while comparing to the previous closing price of $0.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $64.50 and as low as $0.28.
Taking a look at 20-day trading activity of Sunshine Biopharma Inc (SBFM) gives us an average price of $0.3183, while its current price level is -99.58% below from 52-week high level whereas it is -4.27% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4334 while that of 200 days or SMA-200 reads an average of $12.7819. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.43% during that period while stretching the period over a month that increases to 10.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 32.54 which implies that the stock is in neutral territory.
Over the week, SBFM’s stock price is moving -10.89% down while it is -33.21% when we observe its performance for the past one month. Year-to-date it is -99.01% down and over the past year, the stock is showing a downside performance of -99.47%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -4 beat the consensus estimate of -6 for the same. In next quarter, company is expected to be making quarterly sales of $12.6M as analysts are expecting the sales for current fiscal year at $44.4M and seeing the company making $100M in sales next year. Moreover, analysts are in estimates of $9M for current-quarter revenue.
Currently, Sunshine Biopharma Inc’s total number of outstanding shares is 23.41M. Company’s return on investment (ROI) stands at -16.15% and return on equity (ROE) at -18.47%. It has a 0.45 of forward P/E ratio. Stock’s beta reads -0.92. Stock has a price to book (P/B) ratio of 0.01 while price to sale or P/S ratio amounts to 0.24. Its return on asset (ROA) is -13.88% on average.
